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Abstract
Since Hahn’s observation of the postalimentary lipemia clearing actIvity following the injec-
tion of heparin, physiological, biochemical and clinical significances of the postheparin lipoprotein
lipase have been well clarified. The presence of the endogenous lipoprotein lipase in human blood,
which was at first doubted, has been repeatedly confirmed2∼8. Recent papers9,10 described el-
evated endogenous lipoprotein lipase activity in patients with essential hyperlipemia after ample
fat uptake. In this preliminary report, changes of the lipoprotein lipase activity during oral glucose
tolerance test is illustrated.
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Since Hahn's observation of the postalimentary lipemia clearing actIvity
following the injection of heparin, physiological, biochemical and clinical signi-
ficances of the postheparin lipoprotein lipase have been well clarified. The
presence of the endogenous lipoprotein lipase in human blood, which was at
first doubted, has been repeatedly confirmed2- s• Recent papers9. 10 described
elevated endogenous lipoprotein lipase activity in patients with essential hyper-
lipemia after ample fat uptake.
In this preliminary report, changes of the lipoprotein lipase activity during
oral glucose tolerance test is illustrated.
Measurement of the lipoprotein lipase (LPL) activity was performed by
determination of the release of free fatty acid (FFA) in vitroll - 13•
In normal persons (10 cases) (Fig. 1), no LPL activity was demonstrated
in the plasma before and 30, 120 and 180 minutes after glucose intake. And,
elevated LPL activity was observed at 60 and 90, and 150 minutes after glucose
intake, showing two peaks of the LPL activity. After incubation (at 37°C for
half an hour) of the plasma mixed with sesame oil (Fatgen), the identical changes
of the LPL activity curve were observed. But the peaks of the enzymatic acti-
vity of the postincubation plasma were about three times as high as that of the
prcin~ ubation plasma.
In diabetics (9 cases) (Fig. 2), the LPL activity in plasma before incubation
was quite different from changes in normal persons. No activity was observed
before glucose intake, but the activity in the plasma rose at 30, 60 and 90
minutes, when the activity reached a peak, and then the activity decreased 120,
150 and 180 minutes after glucose intake, finally showing almost no activity.
The elevation of the enzymatic activity in diabetics was higher than that in nor-
mal persons. After incubation of the plasma mixed with sesame oil (Fatgen),
identical changes of the LPL activity curve were also observed, demonstrating
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Fig. 1 Plasma LPL and FFA and blood sugar levels in normal persons
A: Preincubation LPL activity (flEq/L) B: Postincubation LPL activity (flEq/L)
C: (Postincubation LPL activity)-(Preincubation LPL activity) (flEq/L) D: FFA
(flEq/L), E: Blood sugar (mg/dl)
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Fig. 2 Plasma LPL and FFA and blood sugar levels in diabetics.
A: Preincubation LPL activity (flEq/L) B: Postincubation LPL activity (flEq/L),
C: (Postincubation LPL activity)-(Preincubation LPL activity) (flEq/L) D: FFA
(JLEq/L), E: Blood sugar (mg/dl)
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Fig. 3 Plasma LPL and FFA and blood sugar levels in patients with cirrhosis of liver
having diabetic GTT curve.
A: Preincubation LPL activity (J.lEqjL) B: Postincubation LPL activity (J.lEq/L),
C: (Postincubation LPL activity)-(Preincubation LPL activity) (pEqjL) D: FFA
CJ.lEqjL), E: Blood_sugar (mgjdl)
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Fig. 4 Plasma LPL and FFA and blood sugar levels in diabetic during insulin sensitivity
test.
A: Preincubation LPL activity CJ.lEq/L), B: Postincubation LPL activity CJ.lEq/L),
C: (postincubation LPL activity) - (Preincubation LPL activity) CJ.lEq/L) D. FFA
(pEq/L). E: Blood sugar (mgjdl)
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a single peak at 90 minutes and no activity before and after glucose tolerance
test. The LPL activity of the postincubation plasma was elevated about twice
as high as that of the preincubation plasma. But differences of the LPL activity
between the pre- and postincubation plasma showed almost same value in normal
persons and diabetics.
FFA levels were decreased until 150 minutes and elevated at 180 minutes
during oral GTT in normals. In diabetics, FFA levels remained elevated for
30 minutes and then .decreased until 150 minutes and again elevated at 180
minutes, keeping higher levels than normals throughout oral GTT.
In patients (3 cases) with cirrhosis of the liver having diabetic GTT curve
(Fig. 3), the LPL activity of the preincubation plasma showed a single peak curve
as in diabetics, but the LPL activity of the postincubation plasma demonstrated
considerably elevated activity before GTT and 180 minutes after glucose intake.
At these moments no LPL activity was usually revealed both of the normal and
diabetic. The enzymatic activity curve showed a single peak curve having the
highest level at 90 minutes as in diabetics.
In insulin sensitive test (Fraser's method14) in the diabetic patient (Fig. 4),
an identical LPL activity curve as in oral GTT of diabetics was observed in spite
of lowered blood sugar level.
These enzymatic activities were completely inhibited by the administration
of protamine sulfate and 10 per cent NaCI solution in vitro.
These observations are clearly demonstrated that this LPL is the endogenous
lipoprotein lipase activated by glucose metabolism and strongly suggested that
this enzyme has some sorts of close relationship with insulin activity in the
human subject.
The endogenous LPL activity was also observed during fat tolerance test
and food uptake.
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